Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia

Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Nature (Impact Factor: 41.46). 11/2011; 481(7381):380-4. DOI: 10.1038/nature10602
Source: PubMed


Acetyl coenzyme A (AcCoA) is the central biosynthetic precursor for fatty-acid synthesis and protein acetylation. In the conventional view of mammalian cell metabolism, AcCoA is primarily generated from glucose-derived pyruvate through the citrate shuttle and ATP citrate lyase in the cytosol. However, proliferating cells that exhibit aerobic glycolysis and those exposed to hypoxia convert glucose to lactate at near-stoichiometric levels, directing glucose carbon away from the tricarboxylic acid cycle and fatty-acid synthesis. Although glutamine is consumed at levels exceeding that required for nitrogen biosynthesis, the regulation and use of glutamine metabolism in hypoxic cells is not well understood. Here we show that human cells use reductive metabolism of α-ketoglutarate to synthesize AcCoA for lipid synthesis. This isocitrate dehydrogenase-1 (IDH1)-dependent pathway is active in most cell lines under normal culture conditions, but cells grown under hypoxia rely almost exclusively on the reductive carboxylation of glutamine-derived α-ketoglutarate for de novo lipogenesis. Furthermore, renal cell lines deficient in the von Hippel-Lindau tumour suppressor protein preferentially use reductive glutamine metabolism for lipid biosynthesis even at normal oxygen levels. These results identify a critical role for oxygen in regulating carbon use to produce AcCoA and support lipid synthesis in mammalian cells.

Download full-text


Available from: Paulo A Gameiro,
  • Source
    • "Under normoxia, up to 25% of fatty acid carbons are derived from glutamine, while up to 80% are glutamine-derived under hypoxia. Reductive carboxylation of glutamine-derived a-ketoglutarate mediated by IDH enzymes contributes to acetyl-CoA synthesis for lipogenesis [Metallo et al., 2011]. However, further analysis demonstrated that fatty acid labeling from glutamine could be explained by isotope exchange without net reductive IDH flux [Fan et al., 2013]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Metabolic networks are significantly altered in neoplastic cells. This altered metabolic program leads to increased glycolysis and lipogenesis and decreased dependence on oxidative phosphorylation and oxygen consumption. Despite their limited mitochondrial respiration, cancer cells, nonetheless, derive sufficient energy from alternative carbon sources and metabolic pathways to maintain cell proliferation. They do so, in part, by utilizing fatty acids, amino acids, ketone bodies and acetate, in addition to glucose. The alternative pathways used in the metabolism of these carbon sources provide opportunities for therapeutic manipulation. Acetate, in particular, has garnered increased attention in the context of cancer as both an epigenetic regulator of posttranslational protein modification, and as a carbon source for cancer cell biomass accumulation. However, to date, the data have not provided a clear understanding of the precise roles that protein acetylation and acetate oxidation play in carcinogenesis, cancer progression or treatment. This review highlights some of the major issues, discrepancies and opportunities associated with the manipulation of acetate metabolism and acetylation-based signaling in cancer development and treatment. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
    Journal of Cellular Biochemistry 08/2015; DOI:10.1002/jcb.25305 · 3.26 Impact Factor
  • Source
    • "Other metabolomics flux experiments have employed GC–MS to trace central carbon metabolism. Such studies include the finding that the reductive metabolism of a-ketoglutarate contributes to de novo lipogenesis (Metallo et al, 2012), the characterization of FH-deficient cells in renal cancer (Frezza et al, 2011b), the study of glutamine dynamics in pancreatic ductal adenocarcinoma (PDAC) (Son et al, 2013), as well as the study of glutamine-associated changes in glioma cells during impaired mitochondrial pyruvate transport (Yang et al, 2014). Metabolomic approaches have been additionally used to detect cancer-specific biomarkers in body fluids. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cancer cells have fundamentally altered cellular metabolism that is associated with their tumorigenicity and malignancy. In addition to the widely studied Warburg effect, several new key metabolic alterations in cancer have been established over the last decade, leading to the recognition that altered tumor metabolism is one of the hallmarks of cancer. Deciphering the full scope and functional implications of the dysregulated metabolism in cancer requires both the advancement of a variety of omics measurements and the advancement of computational approaches for the analysis and contextualization of the accumulated data. Encouragingly, while the metabolic network is highly interconnected and complex, it is at the same time probably the best characterized cellular network. Following, this review discusses the challenges that genome-scale modeling of cancer metabolism has been facing. We survey several recent studies demonstrating the first strides that have been done, testifying to the value of this approach in portraying a network-level view of the cancer metabolism and in identifying novel drug targets and biomarkers. Finally, we outline a few new steps that may further advance this field. © 2015 The Authors. Published under the terms of the CC BY 4.0 license.
    Molecular Systems Biology 06/2015; 11(6):817. DOI:10.15252/msb.20145307 · 10.87 Impact Factor
  • Source
    • "As is well known, in the absence of glucose, glutamine is the major substrate available to the cells. In skeletal muscle, glutamine can act as a nitrogen donor for the synthesis of proteins and nucleosides [34] and be converted to -KG, thereby supporting anaplerotically the TCA cycle or be reductively transformed by cytosolic IDH1 to citrate [35] [36] [37] [38]. Moreover, the hypoxic skeletal muscle promotes an over-expression of PHD2, thereby blunting HIF stabilization and sustaining anabolic substrates production [39]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study employed differential proteomic and immunoassay techniques to elucidate the biochemical mechanisms utilized by human muscle (vastus lateralis) in response to high altitude hypoxia exposure. Two groups of subjects, participating in a medical research expedition (A, n = 5, 19d at 5300m altitude; B, n = 6, 66d up to 8848m) underwent a ≈ 30% drop of muscular creatine kinase and of glycolytic enzymes abundance. Protein abundance of most enzymes of the tricarboxylic acid cycle and oxidative phosphorylation was reduced both in A and, particularly, in B. Restriction of α-ketoglutarate toward succinyl-CoA resulted in increased prolyl hydroxylase 2 and glutamine synthetase. Both A and B were characterized by a reduction of elongation factor 2alpha, controlling protein translation, and by an increase of heat shock cognate 71 kDa protein involved in chaperone-mediated autophagy. Increased protein levels of catalase and biliverdin reductase occurred in A alongside a decrement of voltage-dependent anion channels 1 and 2 and of myosin-binding protein C, suggesting damage to the sarcomeric structures. This study suggests that during acclimatization to hypobaric hypoxia the muscle behaves as a producer of substrates activating a metabolic reprogramming able to support anaplerotically the TCA cycle, to control protein translation, to prevent energy expenditure and to activate chaperone-mediated autophagy. This article is protected by copyright. All rights reserved.
    Proteomics 01/2015; 15(1). DOI:10.1002/pmic.201400306 · 3.81 Impact Factor
Show more